• Bausch Health’s Salix will present severe alcohol-associated hepatitis research at The Liver Meeting Nov. 5-9, 2026, in Denver.
• The study of 1,630 U.S. adults found substantial mortality and rehospitalization, highlighting the need for better disease management and effective therapies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202611060700CANADANWCANADAPR_C8071) on November 06, 2026, and is solely responsible for the information contained therein.